AbVacc, Inc.
Industry
- Pharmaceuticals
- Vaccines
- Biotechnology
- Large Molecule
- Antibodies
- Large Molecule
See more in Biomedtracker
Latest on AbVacc, Inc.
Scrip
• By Joseph Haas
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Organon Will Market Lilly’s Emgality, R
Scrip
• By Joseph Haas, Jung Won Shin, and Dexter Jie Yan
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Dragonfly Takes Back IL-12 Immunotherap